Nardilysin-Dependent Proteolysis of Cell-Associated VTCN1 (B7-H4) Marks Type 1 Diabetes Development

por Radichev, Ilian A., Maneva-Radicheva, Lilia V., Amatya, Christina, Parker, Camille, Ellefson, Jacob, Wasserfall, Clive, Atkinson, Mark, Burn, Paul, Savinov, Alexei Y.
Publicado 2014

Development of a bicistronic anti-CD19/CD20 CAR construct including abrogation of unexpected nucleic acid sequence deletions

por Lam, Norris, Finney, Richard, Yang, Shicheng, Choi, Stephanie, Wu, Xiaolin, Cutmore, Lauren, Andrade, Jorge, Huang, Lei, Amatya, Christina, Cam, Margaret, Kochenderfer, James N.
Publicado 2023

Preclinical Characterization of Recombinant Human Tissue Kallikrein-1 as a Novel Treatment for Type 2 Diabetes Mellitus

por Kolodka, Tadeusz, Charles, Matthew L., Raghavan, Arvind, Radichev, Ilian A., Amatya, Christina, Ellefson, Jacob, Savinov, Alexei Y., Nag, Abhijeet, Williams, Mark S., Robbins, Mark S.
Publicado 2014

Autoimmune Diabetes Is Suppressed by Treatment with Recombinant Human Tissue Kallikrein-1

por Maneva-Radicheva, Lilia, Amatya, Christina, Parker, Camille, Ellefson, Jacob, Radichev, Ilian, Raghavan, Arvind, Charles, Matthew L., Williams, Mark S., Robbins, Mark S., Savinov, Alexei Y.
Publicado 2014